Two-Year shot study aims to protect southern women from HIV
NCT ID NCT06145854
Summary
This study is observing 100 women in the Southern U.S. who are using a long-acting injection called Cabotegravir (CAB-LA) to prevent HIV. Researchers will track how well women stick with the injection schedule over two years and monitor their health outcomes. The goal is to understand how this prevention method works in everyday life outside of a controlled clinical trial.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Midway Specialty Care Center
Orlando, Florida, 32819, United States
-
Midway Specialty Care Center
Temple Terrace, Florida, 33617, United States
-
Midway Specialty Care Center
West Palm Beach, Florida, 33401, United States
Conditions
Explore the condition pages connected to this study.